Page last updated: 2024-10-24

regulation of nucleotide-excision repair

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of nucleotide-excision repair. [GOC:jp, PMID:18836076]

Nucleotide-excision repair (NER) is a crucial DNA repair pathway responsible for removing a wide range of bulky DNA lesions, including those induced by ultraviolet (UV) radiation, chemicals, and oxidative damage. This process involves several steps, each catalyzed by specialized proteins, to ensure efficient and accurate repair of damaged DNA.

1. **Damage Recognition:** NER begins with the detection of DNA damage by specific proteins. In eukaryotes, the damage recognition step is mediated by two distinct sub-pathways: global genome repair (GGR) and transcription-coupled repair (TCR).
* **GGR** scans the entire genome for lesions, utilizing a complex of proteins including XPC, RAD23B, and centrin 2. This complex binds to distorted DNA, indicating the presence of damage.
* **TCR** specifically targets lesions that block transcription, employing a complex of RNA polymerase II (RNAPII), CSA, and CSB. This pathway prioritizes the repair of actively transcribed genes, ensuring their continued function.

2. **Damage Verification and Dual Incision:** Once the damage is recognized, a verification step occurs to confirm the presence of a lesion. In GGR, the XPC-RAD23B complex recruits the TFIIH complex, which contains a DNA helicase and a kinase. The helicase unwinds the DNA around the damage, while the kinase phosphorylates XPC, further stabilizing the complex. In TCR, CSA and CSB interact with stalled RNAPII and facilitate recruitment of the TFIIH complex.
* After verification, the TFIIH complex initiates the critical dual incision step. Two endonucleases, XPF-ERCC1 and XPG, are recruited to the damage site. XPF-ERCC1 makes a 5' incision a few nucleotides upstream of the lesion, while XPG makes a 3' incision downstream. This creates a short single-stranded DNA fragment containing the damage.

3. **Excision and Resynthesis:** The damaged DNA fragment is excised by a complex of proteins including the DNA helicase XPD and the 5'-3' exonuclease DNA2. The gap left behind is filled by DNA polymerase using the undamaged strand as a template.

4. **Ligation:** Finally, the newly synthesized DNA strand is joined to the original strand by DNA ligase, completing the repair process.

The regulation of NER is crucial for maintaining genomic integrity and preventing the accumulation of mutations that can lead to cancer and other diseases. Several factors influence NER regulation, including:

* **Transcriptional Control:** The expression levels of NER proteins are regulated by various transcription factors, ensuring their appropriate production in response to DNA damage.
* **Post-Translational Modifications:** NER proteins undergo various modifications, such as phosphorylation and ubiquitination, which influence their activity, stability, and interactions with other proteins.
* **Cellular Stress Responses:** Cells activate specific stress responses, including the DNA damage response pathway, to coordinate NER with other repair pathways and cellular processes.

Understanding the complex mechanisms involved in the regulation of NER is critical for developing strategies to enhance DNA repair and prevent disease. '
"

Proteins (6)

ProteinDefinitionTaxonomy
Bromodomain-containing protein 7A bromodomain-containing protein 7 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9NPI1]Homo sapiens (human)
Protein polybromo-1A protein polybromo-1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q86U86]Homo sapiens (human)
Cullin-4AA cullin-4A that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q13619]Homo sapiens (human)
Transcription activator BRG1A transcription activator BRG1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P51532]Homo sapiens (human)
Probable global transcription activator SNF2L2A probable global transcription activator SNF2L2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P51531]Homo sapiens (human)
DNA repair protein RAD52 homologA DNA repair protein RAD52 homolog that is encoded in the genome of human. [PRO:DNx]Homo sapiens (human)

Compounds (28)

CompoundDefinitionClassesRoles
aurintricarboxylic acidaurintricarboxylic acid : A member of the class of quinomethanes that is 3-methylidene-6-oxocyclohexa-1,4-diene-1-carboxylic acid in which the methylidene hydrogens are replaced by 4-carboxy-3-hydroxyphenyl groups. The trisodium salt is the biological stain 'chrome violet CG' while the triammonium salt is 'aluminon'.

Aurintricarboxylic Acid: A dye which inhibits protein biosynthesis at the initial stages. The ammonium salt (aluminon) is a reagent for the colorimetric estimation of aluminum in water, foods, and tissues.
monohydroxybenzoic acid;
quinomethanes;
tricarboxylic acid
fluorochrome;
histological dye;
insulin-like growth factor receptor 1 antagonist
gossypolGossypol: A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer.
lobenzaritlobenzarit: prevents autoimmune kidney disease in hybrid mice; RN given refers to parent cpdaminobenzoic acid
oxidopamineoxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).

Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
benzenetriol;
catecholamine;
primary amino compound
drug metabolite;
human metabolite;
neurotoxin
1,2,5,8-tetrahydroxy anthraquinone1,2,5,8-tetrahydroxy anthraquinone: structure in first source

quinalizarin : A tetrahydroxyanthraquinone having the four hydroxy groups at the 1-, 2-, 5- and 8-positions.
tetrahydroxyanthraquinoneEC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
3-acetylindole3-acetylindole: structure in first source
epigallocatechin gallate(-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin.

epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis)
flavans;
gallate ester;
polyphenol
antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
epicatechin(-)-epicatechin : A catechin with (2R,3R)-configuration.catechin;
polyphenol
antioxidant
gallocatechol(-)-epigallocatechin : A flavan-3,3',4',5,5',7-hexol having (2R,3R)-configuration.catechin;
flavan-3,3',4',5,5',7-hexol
antioxidant;
food component;
plant metabolite
strictininstrictinin: antioxidant from green tea leaves (Camellia sinensis L.); structure in first source
corilagincorilagin : An ellagitannin with a hexahydroxydiphenoyl group bridging over the 3-O and 6-O of the glucose core.

corilagin: isolated from Geranii herba
ellagitannin;
gallate ester
antihypertensive agent;
antioxidant;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
non-steroidal anti-inflammatory drug
6-hydroxydopa6-hydroxydopa: RN given refers to cpd without isomeric designationnon-proteinogenic alpha-amino acid
epicatechin gallate(-)-epicatechin-3-O-gallate : A gallate ester obtained by formal condensation of the carboxy group of gallic acid with the (3R)-hydroxy group of epicatechin. A natural product found in Parapiptadenia rigida.

epicatechin gallate: a steroid 5alpha-reductase inhibitor; RN given refers to the (cis)-isomer; structure given in first source; isolated from green tea
catechin;
gallate ester;
polyphenol
EC 3.2.1.1 (alpha-amylase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
metabolite
asiatic acidmonocarboxylic acid;
pentacyclic triterpenoid;
triol
angiogenesis modulating agent;
metabolite
4-pyridin-4-yl-2-sulfanylidene-5,6,7,8-tetrahydro-1H-quinoline-3-carbonitrilebipyridines
tg 003TG 003: a Clk inhibitor; structure in first source
2,4-Di(3-pyridyl)-1,3-thiazolethiazoles
5-Methyl-6-(2-thienyl)-2,3,4,5-tetrahydropyridazin-3-onepyridazines
luteolin3'-hydroxyflavonoid;
tetrahydroxyflavone
angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist
gossypetingossypetin : A hexahydroxyflavone having the hydroxy groups placed at the 3-, 3'-, 4'-, 5- 7- and 8-positions.

gossypetin: inhibits activity of penicillinase enzyme in E coli
7-hydroxyflavonol;
hexahydroxyflavone
plant metabolite
3-(4-chlorophenyl)-1-methyl-N-[3-(1-pyrrolidinyl)propyl]-5-thieno[2,3-c]pyrazolecarboxamidepyrazoles;
ring assembly
su 11248monocarboxylic acid amide;
pyrroles
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
immunomodulator;
neuroprotective agent;
vascular endothelial growth factor receptor antagonist
cedrelonecedrelone: from Toona ciliata; structure in first sourcelimonoid
i-bet726
rolitetracyclinerolitetracycline : A derivative of tetracycline in which the amide function is substituted with a pyrrolidinomethyl group.

Rolitetracycline: A pyrrolidinylmethyl TETRACYCLINE.
methacycline monohydrochloride
pf-06687252PF-06687252: a SMARCA2/4 bromodomain inhibitor; structure in first source

PFI-3 : An azabicycloalkane that is (1R,4R)-2,5-diazabicyclo[2.2.1]heptane which is substituted at position 2 by a 3-(2-hydroxyphenyl)-3-oxoprop-1-en-1-yl group and at position 5 by a pyridin-2-yl group. It is a potent and selective inhibitor of polybromo 1 (Kd = 48 nM), SMARCA2 and SMARCA4 (Kd = 89 nM) bromodomains.
azabicycloalkane;
enone;
phenols;
pyridines
pf-477736PF 00477736: a Chk1 inhibitor; structure in first source

PF-00477736 : A diazepinoindole that is 8-amino-4,5-dihydro-6H-[1,2]diazepino[4,5,6-cd]indol-6-one which is substituted at position 2 by a 1-methylpyrazol-4-yl group and in which the amino group at position 8 has undergone condensation with the carboxy group of (2R)-2-cyclohexylglycine to give the corresponding carboxamide. It is an inhibitor of checkpoint kinase 1 (Chk 1).